Top compounds associated with response to ANXA2R


Feature Type Standardized
Nominal ANOVA
mRNA tigecycline CTRPv2 pan-cancer AAC 0.18 0.0005
mRNA Topotecan CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA KW-2449 CTRPv2 pan-cancer AAC 0.099 0.002
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 0.002
Download CSV